Calcium Entry Blockers in Cardiovascular and Cerebral Dysfunctions: Developments in Cardiovascular Medicine, cartea 40
Editat de T. Godfraind, A.G. Herman, D. Wellensen Limba Engleză Paperback – 4 noi 2011
Din seria Developments in Cardiovascular Medicine
- 5% Preț: 1484.50 lei
- 5% Preț: 375.17 lei
- 5% Preț: 354.10 lei
- 5% Preț: 1395.07 lei
- 5% Preț: 370.13 lei
- 5% Preț: 1079.75 lei
- 5% Preț: 1414.09 lei
- 5% Preț: 370.48 lei
- 5% Preț: 362.20 lei
- 5% Preț: 373.89 lei
- 5% Preț: 2081.76 lei
- 5% Preț: 361.13 lei
- 5% Preț: 360.41 lei
- 5% Preț: 364.90 lei
- 5% Preț: 364.74 lei
- 5% Preț: 769.99 lei
- 5% Preț: 701.16 lei
- 5% Preț: 1079.75 lei
- 5% Preț: 369.21 lei
- 5% Preț: 367.23 lei
- 5% Preț: 711.74 lei
- 5% Preț: 1085.49 lei
- 5% Preț: 2081.42 lei
- 5% Preț: 704.03 lei
- 5% Preț: 365.80 lei
- 5% Preț: 710.17 lei
- 5% Preț: 648.98 lei
- 5% Preț: 369.06 lei
- 5% Preț: 1399.20 lei
- 5% Preț: 703.32 lei
- 5% Preț: 777.36 lei
- 5% Preț: 708.53 lei
- 5% Preț: 3131.58 lei
- 5% Preț: 1394.33 lei
- 5% Preț: 771.42 lei
- 5% Preț: 702.60 lei
- 5% Preț: 364.54 lei
- 5% Preț: 369.93 lei
- 5% Preț: 649.73 lei
- 5% Preț: 362.20 lei
Preț: 356.67 lei
Preț vechi: 375.45 lei
-5% Nou
Puncte Express: 535
Preț estimativ în valută:
68.29€ • 71.11$ • 56.66£
68.29€ • 71.11$ • 56.66£
Carte tipărită la comandă
Livrare economică 10-15 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789400960350
ISBN-10: 9400960352
Pagini: 336
Ilustrații: 325 p.
Dimensiuni: 156 x 244 x 18 mm
Ediția:Softcover reprint of the original 1st ed. 1984
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9400960352
Pagini: 336
Ilustrații: 325 p.
Dimensiuni: 156 x 244 x 18 mm
Ediția:Softcover reprint of the original 1st ed. 1984
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
I: Introductory considerations.- The major steps in the discovery of calcium entry blockers..- Basic mechanisms and classification of calcium entry blockers..- Calcium entry blockers: perspectives..- Twenty-seven calcium entry blockers in development: a new chapter in pharmacology..- II: Calcium entry blockers and peripheral circulatory function..- Calcium-ions and excitation contraction coupling in vascular smooth muscle cells..- Laser microprobe mass analysis (LAMMA) as a technique to quantitate Ca2+ ions..- Vascular pharmacology of calcium entry blockers..- Calcium homeostasis in human red blood cells..- Impact of Ca2+ entry blockers on Ca2+ dependent mechanisms in red blood cells, platelets and endothelial cells..- Red blood cell microrheology and calcium antagonists..- Calcium e ntry blockers in the treatment of peripheral obliterative arterial disease..- III: Calcium entry blockers and myocardial function..- Pharmacology of calcium entry blockers in animal and human coronary arteries..- Calcium paradox and calcium entry blockers..- Myocardial oxygen deprivation and calcium deprivation: ultrastructural characteristics and clinical significance..- Basic and clinical aspects of myocardial protection by calcium entry blockers..- Effect of calcium entry blockers on impaired left ventricular wall motion..- The influence of Ca2+ entry blockers on hemodynamics and coronary blood flow, and its importance for the treatment of angina pectoris..- The use of selective calcium antagonism in variant (vasospastic) and classical (effort) angina pectoris..- Calcium entry blockers in cardiovascular therapy. Influence of diltiazem on hemodynamics and coronary blood flow..- IV: Calcium entry blockers and cerebral function..- Calcium entry blockers and cerebral function: an introduction..- Calcium entry blockers and cerebral resuscitation..- Effect of calcium entry blockers in models of brain hypoxia..- Calcium entry blockers in the therapy of vertebrobasilar insufficiency..- Calcium entry blockers and pharmacological aspects of migraine..- Clinical evaluation of calcium entry blockers in migraine..- V: Calcium entry blockers in hypertension treatment..- Double-blind comparison of the antihypertensive effects of verapamil and nifedipine..- Treatment of hypertension emergencies and chronic arterial hypertension with calcium entry blockers..- The effect of nifedipine on arterial pressure and reflex cardiac control..- Concluding remarks.- Why are Ca2+ entry blockers effective in the treatment of hypertension and tissue hypoxia?.- List of authors and co-authors.